Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFSAN Deputy Director Landa Brings First-Hand Health Claims Experience

This article was originally published in The Tan Sheet

Executive Summary

Incoming CFSAN Regulatory Affairs Deputy Director Michael Landa could prove to be a central figure as the center issues and implements its qualified health claims framework

You may also be interested in...



Health Claims Proposal To Be Informed By FDA, FTC Consumer Research

FDA expects to release its qualified health claims proposed rule this fall, pending review of public comments and agency-sponsored label comprehension research

FDA Qualified Health Claims Notice Leans Toward Ranking System

Codifying the current interim evidence-based ranking system for qualified health claims would preserve the current premarket review system already in place and bestow the most benefits, FDA states in an 1advance notice of proposed rulemaking on health claims published in the Nov. 25 Federal Register

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097056

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel